Diabetes 50:1943-1948, 2001
© 2001 by the American Diabetes Association, Inc.
Susceptibility and Negative Epistatic Loci Contributing to Type 2 Diabetes and Related Phenotypes in a KK/Ta Mouse Model
Toshihide Shike1,
Sachiko Hirose2,
Michimasa Kobayashi1,
Kazuhiko Funabiki1,
Toshikazu Shirai2, and
Yasuhiko Tomino1
1 Division of Nephrology, Department of Medicine, and the
2 Department of Pathology, Juntendo University School of Medicine, Tokyo, Japan
The KK/Ta mouse strain serves as a suitable polygenic model for human type 2 diabetes. Using 93 microsatellite markers in 208 KK/Ta x (BALB/c x KK/Ta)F1 male backcross mice, we carried out a genome-wide linkage analysis of KK/Ta alleles contributing to type 2 diabetes and related phenotypes, such as obesity and dyslipidemia. We identified three major chromosomal intervals significantly contributing to impaired glucose metabolism: one quantitative trait locus for impaired glucose tolerance on chromosome 6 and two loci for fasting blood glucose levels on chromosomes 12 and 15. The latter two loci appeared to act in a complementary fashion. Two intervals showed significant linkages for serum triglyceride levels, one on chromosome 4 and the other on chromosome 8. The KK allele on chromosome 8 acts to promote serum triglyceride levels, whereas the KK allele on chromosome 4 acts to suppress this effect in a recessive fashion. In addition, it is suggested that the chromosome 4 locus also acts to downregulate body weight and that the chromosome 8 locus acts to upregulate serum insulin levels. Our data clearly showed that each disease phenotype of type 2 diabetes and related disorders in KK/Ta mice is under the control of separate genetic mechanisms. However, there appear to be common genes contributing to different disease phenotypes. There are potentially important candidate genes that may be relevant to the disease.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Clee and A. D. Attie
The Genetic Landscape of Type 2 Diabetes in Mice
Endocr. Rev.,
February 1, 2007;
28(1):
48 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Su, Y. Li, J. C. James, M. McDuffie, A. H. Matsumoto, G. A. Helm, J. L. Weber, A. J. Lusis, and W. Shi
Quantitative Trait Locus Analysis of Atherosclerosis in an Intercross Between C57BL/6 and C3H Mice Carrying the Mutant Apolipoprotein E Gene
Genetics,
March 1, 2006;
172(3):
1799 - 1807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shike, T. Gohda, M. Tanimoto, M. Kobayashi, Y. Makita, K. Funabiki, S. Horikoshi, S. Hirose, T. Shirai, and Y. Tomino
Chromosomal mapping of a quantitative trait locus for the development of albuminuria in diabetic KK/Ta mice
Nephrol. Dial. Transplant.,
May 1, 2005;
20(5):
879 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang and B. Paigen
Genetics of Variation in HDL Cholesterol in Humans and Mice
Circ. Res.,
January 7, 2005;
96(1):
27 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Fan, J. Liao, M. Kobayashi, M. Yamashita, L. Gu, T. Gohda, Y. Suzuki, L. N. Wang, S. Horikoshi, and Y. Tomino
Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice
Nephrol. Dial. Transplant.,
December 1, 2004;
19(12):
3012 - 3020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, R. Korstanje, D. Higgins, and B. Paigen
Haplotype Analysis in Multiple Crosses to Identify a QTL Gene
Genome Res.,
September 1, 2004;
14(9):
1767 - 1772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gohda, Y. Makita, T. Shike, M. Tanimoto, K. Funabiki, S. Horikoshi, and Y. Tomino
Identification of Epistatic Interaction Involved in Obesity Using the KK/Ta Mouse as a Type 2 Diabetes Model: Is Zn-{alpha}2 Glycoprotein-1 a Candidate Gene for Obesity?
Diabetes,
August 1, 2003;
52(8):
2175 - 2181.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|